Stem Cells in the Media: the Emergence of Public Understanding of a New Technology

@article{Murad2006StemCI,
  title={Stem Cells in the Media: the Emergence of Public Understanding of a New Technology},
  author={A. Najib Murad and D. Jane Bower and Julian C. Sulej},
  journal={Proceedings of the 14th Annual High Technology Small Firms Conference and Doctoral Workshop 2006},
  year={2006}
}
The failure of the introduction to Europe of GM foods illustrates how negative public perception of a novel technology can block the development of new products and services in spite of major corporate and governmental investment. Stem cell technology is a novel technology which holds out the promise of improved treatments for many major diseases. However stem cell research is a highly controversial area of life science. This is mainly due to the use of human embryos, which are one of the… 

Figures and Tables from this paper

Blazing the trail from stem cell research to regenerative medicine
TLDR
The issues surrounding stem cell developments are reviewed and the possible implications of the trends in media coverage are discussed.

References

SHOWING 1-10 OF 66 REFERENCES
Realistic prospects for stem cell therapeutics.
TLDR
A framework for appreciating the promise of regenerative medicine while at the same time understanding the challenges behind translating fundamental stem cell biology into novel clinical therapies is provided.
Stem cells and the future of regenerative medicine
TLDR
Stem Cells and the Future of Regenerative Medicine provides a deeper exploration of the biological, ethical, and funding questions prompted by the therapeutic potential of undifferentiated human cells and provides an overview of the moral and ethical problems that arise from the use of embryonic stem cells.
The business of human embryonic stem cell research and an international analysis of relevant laws.
Few sciences have held out such therapeutic promise and correspondingly stirred so much controversy in countries throughout the world as the developing science surrounding human embryonic stem cells.
The business of human embryonic stem cell research and an international analysis of relevant laws.
Few sciences have held out such therapeutic promise and correspondingly stirred so much controversy in countries throughout the world as the developing science surrounding human embryonic stem cells.
Public Opinion About Stem Cell Research and Human Cloning
TLDR
The study of survey trends detailing public responses to genetic engineering and biotechnology is not new but previous analyses have not focused on surveys measuring public reactions either to stem cell or therapeutic cloning research.
The Ethics and Politics of Small Sacrifices in Stem Cell Research
TLDR
An ethical argument can be made that it is justifiable to modify or destroy certain human embryos in the pursuit of cures for dread and lethal diseases, and until this argument is made, the case for stem cell research will rest on political foundations rather than on the ethical foundations that the funding of stem cellResearch requires.
Replicating Our Bodies, Losing Our Selves: News Media Portrayals of Human Cloning in the Wake of Dolly
According to recent news reports, developments in biotechnology promise to transform our bodies and our lives. Stem cell research and cloning research are reported to offer us the prospect of being
A Response to Commentators on "Human Embryo Research and the Language of Moral Uncertainty"
TLDR
The findings confirm that even among scientific and philosophical experts a diversity of opinion exists on society's moral obligations to nascent human life and the value of vulnerable human life is trivialized alongside sensational assertions of anticipated medical cures.
Can Adult Stem Cells Suffice?
TLDR
For some diseases, adult cells may indeed turn out to be the better choice, but for other applications, embryo-derived cells have some distinct advantages.
From the ‘rhetoric of hope’ to the ‘patient-active paradigm’—strategic positioning of pharmaceutical and biotechnology companies
  • D. Bower
  • Engineering
    Technol. Anal. Strateg. Manag.
  • 2005
TLDR
It is proposed that this overt repositioning of pharmaceutical and biotechnology companies in relation to patients and the wider public between 1990 and 2002 is linked to their success in gaining public acceptance of their use of genetics-based technologies to develop novel products.
...
...